CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- 4 Shares withheld for taxes President and CEO gave up 170 shares (to pay taxes)
- 4 Open-market sale Director sold 200 shares at $540.80 ($108,160)
- 4 Exercise or conversion Director acquired 257 shares (option exercise)
- 4 Gift Director gave 257 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 339 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 257 shares (option exercise)
- 4 Exercise or conversion Director acquired 257 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 208 shares (option exercise)
- 4 Exercise or conversion Director acquired 257 shares (option exercise)
- 4 Open-market sale Executive Vice President sold 8,104 shares at an average $558.44 ($4,525,596)
- 4 Open-market sale Director sold 1,404 shares at $562.98 ($790,427)
- 4 Gift President and CEO gave 550 shares (gift)
- 4 Exercise or conversion President and CEO acquired 483 shares (option exercise)
- 4 Exercise or conversion EVP, GC & Corporate Secretary acquired 483 shares (option exercise)
- 4 Exercise or conversion EVP, CFO and Treasurer acquired 483 shares (option exercise)
- 4 Shares withheld for taxes EVP, GC & Corporate Secretary gave up 356 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 108 shares (to pay taxes)
Page 6 of 74 · 1,467 filings